ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 760

Use of Multiplex Cytokine Analysis of Dermal Blister Fluid to Assess Local Inflammatory and Immune Activity in Systemic Sclerosis

Kristina E.N. Clark1, Henry Lopez2, Xu Shiwen1, Bahja Ahmed Abdi1, George Martin3, Korsa Khan4, David J. Abraham1, Christopher P. Denton5 and Richard J. Stratton1, 1Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, London, United Kingdom, 2Murigenics, Vallejo, CA, 3Aero Dap, Vallejo, CA, 4Centre for Rheumatology and Connective Tissue Diseases, UCL medical School, London, United Kingdom, 5Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School Royal Free Campus, London, United Kingdom

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Biomarkers, chemokines, cytokines, scleroderma and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose

Clinical diversity in systemic sclerosis (SSc) suggests complex multifaceted pathogenesis involving interplay of growth factors or cytokines within the lesional microenvironment.  We analysed dermal suction blister fluid to investigate protein expression in skin of SSc patients and healthy controls.  We compared the levels of key candidate proteins that may be relevant to pathogenesis.

Methods

Blister fluid (BF) samples from the forearm skin of patients (n=25; DcSSc =19, LcSSc=6) or healthy controls (HC)(n=10) were collected using a dermal suction blister method with paired serum samples, and profiled by Luminex array. Permutation analysis was used for statistical testing.

Results

BF: Profiling showed increased inflammatory cytokines (mean IL-6 in SSc- 77.2 pg/ml, HC-17.8 pg/ml, p=0.009, mean IL-17 in SSc-0.61 pg/ml, HC- 0 pg/ml, p=0.03), and vascular growth factors (PDGF-aa 16.4 pg/ml in SSc, HC-0.97 pg/ml, p=0.049). Additionally MCP-3 (CCL7), IL-15 and IFN-g were all significantly increased in SSc (p<0.05).  Plasma: 19/26 SSc patients, and 8/10 HCs were available. Proteins that were significantly raised (p<0.05) in plasma compared to HC, that were also raised in BF were MCP-3 (p=0.025), IL-15 (p=0.02) and IL-6 (p=0.04). Also raised in plasma were IL-1Rα, IL-1a, IL-12p40, GM-CSF, IL-2, IL-4, IL-9, Flt-3L and VEGF (all p<0.05).  Of interest Th2 cytokines IL-4, 5, and 13, were only detectable in SSc plasma.

Proinflammatory cytokines (IL-6 (p=0.23), IL-17 (p=0.56)), and growth factors (VEGF(,p=0.47), PDGF(p=0.22)) showed no correlation between serum samples and BF.  The healthy controls showed greater correlation between BF and serum, often reaching significance (IL-10,MCP-3,IL1ra,FGF-2).

Heatmaps of BF (Figure 1). Unbiased BF analysis by CIMminer (NIH) revealed clustering of SSc patients into 3 groups; Group 1, high IL-6, IL-10, TNFα, and IL-1α high (innate) consisted of mainly early DcSSc with high skin score. Group 2 comprised late stage DcSSc with increased levels of IFNγ, IL-2, IL-4, IL-5, MCP-3, IL12p40, IL12p70 (adaptive). Group3 quiescent with low levels of cytokines and chemokines, and LcSSc or DcSSc patients with low skin score. Plasma analysis did not cluster into distinct clinical groups.  ANOVA showed significant difference between skin scores (p=0.003), with Scheffe post hoc analysis showing significant higher skin scores in Group 1 (p=0.005).

Conclusion

Our results confirm the value of dermal blister analysis in SSc, and identify key factors expressed locally. Whilst plasma analysis revealed some overlap with the blister fluid analysis, it did not reflect all of the changes present in the dermal microenvironment. This method profiles the local inflammatory process occurring within the skin and complements clinical and gene expression based classification, as well as suggesting markers of disease activity or treatment effect.

 


Disclosure:

K. E. N. Clark,
None;

H. Lopez,
None;

X. Shiwen,
None;

B. Ahmed Abdi,
None;

G. Martin,
None;

K. Khan,
None;

D. J. Abraham,
None;

C. P. Denton,
None;

R. J. Stratton,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/use-of-multiplex-cytokine-analysis-of-dermal-blister-fluid-to-assess-local-inflammatory-and-immune-activity-in-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology